The global chemiluminescence immunoassay market size is expected to reach USD 15.50 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 4.6% from 2024 to 2030. The high prevalence of chronic diseases, several advantages of chemiluminescence immunoassay (CLIA) technique, and approval and launch of novel CLIA solutions are anticipated to be the major factors driving the market.
Chemiluminescence Immunoassay Market Report Highlights
- Based on product, consumables dominated the market in 2023 owing to their high demand in therapeutic drug monitoring, endocrinology, and disease diagnosis
- In terms of application, the infectious disease segment held the largest share in 2023 owing to the high prevalence of such diseases and the launch of novel CLIA assays for infectious disease diagnosis
- By end use, in 2020, the hospitals segment accounted for the largest share in 2023 owing to the increasing hospitalizations, along with the rising prevalence of chronic diseases
- In North America, the U.S. held the largest share in 2023 owing to the developed healthcare infrastructure, the high adoption of technologically advanced CLIA systems, and the strong geographical presence of prominent players
- Asia Pacific is expected to expand at the fastest CAGR during the forecast period. The emergence of local players in developing markets, such as India and China, is primarily driving the regional market
For More Details or Sample Copy please visit link @: Chemiluminescence Immunoassay Market Report
Key players in the market are implementing organic and inorganic growth strategies for the development, launch, and distribution of novel CLIA solutions. For instance, in February 2020, Snibe Diagnostic, a China-based immunoassay manufacturer, received CE marking for its new MAGLUMI 2019-nCoV (SARS-CoV-2) IgM/IgG CLIA kits. In another instance, in January 2018, DiaSorin partnered with Germany-based Qiagen and added Qiagen’s QuantiFERON-TB diagnostic test portfolio to its LIAISON family of fully automated chemiluminescence immunoassay analyzers. Such initiatives by major players are anticipated to significantly support the market growth. However, the high setup cost of automated chemiluminescence immunoassay systems is expected to be a major factor hindering the market growth.
Furthermore, the high prevalence of chronic diseases in key regions and increasing awareness regarding these diseases in emerging economies are anticipated to upsurge the demand for novel diagnostic solutions, including chemiluminescence immunoassay. According to the data published by the American Cancer Society, in 2020, an estimated 1.8 million new cases of cancer were diagnosed in the U.S. and around 606,520 people died due to the disease. In addition, as per the data published by the WHO in November 2020, HIV emerged as a major global public health issue and around 37.9 million people around the globe were living with the disease.
List of major companies in the Chemiluminescence Immunoassay Market
- Abbott Laboratories
- Beckman Coulter Inc.
- DiaSorin S.p.A.
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
- Hoffmann-La Roche AG
- Siemens Healthineers
- Ortho Clinical Diagnostics
For Customized reports or Special Pricing please visit @: Chemiluminescence Immunoassay Market Analysis Report
We have segmented the global chemiluminescence immunoassay market on the basis of product, sample type, application, end-use, and region.
Research Methodology
We employ a comprehensive and iterative research methodology focused on minimizing deviance in order to provide the most accurate estimates and forecasts possible. We utilize a combination of bottom-up and top-down approaches for segmenting and estimating quantitative aspects of the market. Data is continuously filtered to ensure that only validated and authenticated sources are considered. In addition, data is also mined from a host of reports in our repository, as well as a number of reputed paid databases. Our market estimates and forecasts are derived through simulation models. A unique model is created and customized for each study. Gathered information for market dynamics, technology landscape, application development, and pricing trends are fed into the model and analyzed simultaneously.
About Grand View Research
Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S. based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.
Contact:
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll-Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Web: https://www.grandviewresearch.com
#ChemiluminescenceImmunoassay #CLIA #MedicalDiagnostics #Immunoassay #LaboratoryTesting #DiagnosticTechnology #ClinicalDiagnostics #Biotechnology #InVitroDiagnostics #HealthcareInnovation #DiseaseDetection #DiagnosticMarket #HealthcareSolutions #DiagnosticDevices #MedicalResearch
